an investigation into Germany’s pharmaceutical pricing system that could result in tariffs.
In December, the administration entered into a trade deal with the United Kingdom that would exempt U.K. pharmaceuticals from U.S.-imposed tariffs in exchange for Britain paying more for medicines.
The Association for Accessible Medicines (AAM), which represents continue reading …